Administration, Intranasal
"Administration, Intranasal" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Delivery of medications through the nasal mucosa.
MeSH Number(s)
E02.319.267.080
E02.319.267.120.080
Concept/Terms
Administration, Intranasal- Administration, Intranasal
- Intranasal Drug Administration
- Drug Administration, Intranasal
- Intranasal Administration
- Administrations, Intranasal
- Intranasal Administrations
- Administration, Intranasal Drug
- Administrations, Intranasal Drug
- Drug Administrations, Intranasal
- Intranasal Drug Administrations
- Administration, Nasal
- Administrations, Nasal
- Nasal Administration
- Nasal Administrations
Below are MeSH descriptors whose meaning is more general than "Administration, Intranasal".
Below are MeSH descriptors whose meaning is more specific than "Administration, Intranasal".
This graph shows the total number of publications written about "Administration, Intranasal" by people in Harvard Catalyst Profiles by year, and whether "Administration, Intranasal" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1996 | 0 | 4 | 4 |
1997 | 0 | 2 | 2 |
1998 | 0 | 3 | 3 |
1999 | 0 | 3 | 3 |
2000 | 0 | 5 | 5 |
2001 | 0 | 7 | 7 |
2002 | 0 | 9 | 9 |
2003 | 0 | 10 | 10 |
2004 | 0 | 9 | 9 |
2005 | 1 | 8 | 9 |
2006 | 0 | 7 | 7 |
2007 | 1 | 4 | 5 |
2008 | 0 | 8 | 8 |
2009 | 0 | 5 | 5 |
2010 | 0 | 7 | 7 |
2011 | 1 | 12 | 13 |
2012 | 0 | 9 | 9 |
2013 | 1 | 16 | 17 |
2014 | 0 | 9 | 9 |
2015 | 0 | 11 | 11 |
2016 | 0 | 9 | 9 |
2017 | 1 | 11 | 12 |
2018 | 0 | 10 | 10 |
2019 | 1 | 19 | 20 |
2020 | 0 | 16 | 16 |
2021 | 0 | 11 | 11 |
2022 | 0 | 11 | 11 |
2023 | 0 | 10 | 10 |
2024 | 0 | 1 | 1 |
Below are the most recent publications written about "Administration, Intranasal" by people in Profiles.
-
A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration. Sci Rep. 2024 02 15; 14(1):3818.
-
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques. Nature. 2024 Feb; 626(7998):385-391.
-
Nasal Iodophor Antiseptic vs Nasal Mupirocin Antibiotic in the Setting of Chlorhexidine Bathing to Prevent Infections in Adult ICUs: A Randomized Clinical Trial. JAMA. 2023 10 10; 330(14):1337-1347.
-
Nasal administration of anti-CD3 monoclonal antibody ameliorates disease in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A. 2023 09 12; 120(37):e2309221120.
-
Focused ultrasound enhances transgene expression of intranasal hGDNF DNA nanoparticles in the sonicated brain regions. J Control Release. 2023 06; 358:498-509.
-
Intranasal Dexmedetomidine for Pain Management in Older Patients: A Cross-Over, Randomized, Double-Blinded, Active-Controlled Trial. Drugs Aging. 2023 06; 40(6):527-538.
-
Pharmacotherapy: Ketamine and Esketamine. Psychiatr Clin North Am. 2023 06; 46(2):277-290.
-
Nasal administration of anti-CD3 mAb (Foralumab) downregulates NKG7 and increases TGFB1 and GIMAP7 expression in T cells in subjects with COVID-19. Proc Natl Acad Sci U S A. 2023 03 14; 120(11):e2220272120.
-
Clinical Outcomes Associated With Intranasal Dexmedetomidine Sedation in Children. Hosp Pediatr. 2023 03 01; 13(3):223-243.
-
The effects of flow settings during high-flow nasal cannula support for adult subjects: a systematic review. Crit Care. 2023 02 28; 27(1):78.